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BACKGROUND AND METHODS  
A. BACKGROUND AND RATIONALE  
Diabetes related damage is often now preventable with tight metabolic control (e.g. 
glucose, blood pressure, lipids), self care activities, regular review and timely intervention 
(1,2).  However, preventable complications continue to occur (3), often due to personal and 
systems barriers to implementing diabetes care (4,5).  Patients perceive psychological and 
psychosocial issues as important barriers to diabetes care, emphasizing in particular the 
strictness of the diabetes regimen, including diet, exercise and monitoring (6,7).  In the 
DAWN study, self reported success with regimen adherence was relatively low in both 
Type 1 (46%) and Type 2 (39%) diabetes, but greater for self care than lifestyle behaviours 
(8).  The need to overcome such barriers, so that people with diabetes are able to deal with 
the psychological, social and emotional issues that they face has become a major challenge.    
 
A range of self management and structured educational programmes exist which emphasise 
empowerment and the pivotal role of the person with diabetes (9-12).   This is a central theme 
within the Chronic Care Model for disease management (13) and the UK Diabetes National 
Service Framework (14).   However, maintaining this role in managing an asymptomatic 
condition, on a day to day basis, with often unpleasant or obtrusive interventions, can be 
difficult.  Different psychological interventions have been attempted to address this issue with 
varying success (15,16).  Peer support, involving experience sharing, mentoring and role-
modeling, has also been proposed as a way of overcoming some psychosocial barriers.   
Because peer supporters have faced many of the same problems, and the support offered relates 
to the task of managing diabetes in one’s day to day life, peer support has the potential of being 
a practical way to address barriers which have been identified as so important in impeding 
successful diabetes self-management.  A variety of individual and group approaches to 
providing peer support have been developed (9,17-19): 
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 Individual buddy approach: where a patient mentors and supports another patient.  
 Individual expert patient approach: A structured group training programme providing 
“expert” patients with skills to train other patients in self management/problem solving. 
 Traditional self help groups: People meeting for mutual support in a relatively unstructured 
way.  Such groups exist all over the world and although considered important, there has 
been little evaluation of whether they lead to behaviour change or improvements in health.  
 Structured group education approach: Group education incorporating patients learning 
and supporting each other during the course (10,11). 
Previous research suggests that peer support interventions are welcomed by participants, but 
has not provided robust evidence for its utility across all cultures (20).   Two randomized trials 
have suggested improved self efficacy and HbA1c from peer-led self management support 
within Spanish-speaking communities (19) and increased physical activity from peer support 
amongst African-American women (21).  Other trials are underway in Dublin (evaluating group 
support in primary care, including an educational component) (22) and Warwick (evaluating 
telecare by peers) (23).  A model for how peer support could lead to sustainable behavioural 
changes that will improve long-term diabetes outcomes has been proposed by Heisler (17): 
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We wonder whether Heisler’s model focuses on individual interactions between peer and 
person with diabetes, and understates the role of the context and social milieu in which the peer 
support occurs.  This is a key component in Bandura’s social cognitive theory (24), under 
which, people, environment and behaviour are all influencing each other. We have therefore 
included an additional construct of social context which is consistent with Bandura’s Theory, 
can include 1:1 or group/community settings and which may be vital for some individuals.  
Bandura’s approach could provide a framework (Appendix 1) to train peers for a support role, 
and also aid understanding of the ways in which peer support may be helpful (25).   Aspects 
relevant to peer support include promoting self efficacy and motivation, buddying, mentoring 
and modeling within a social context which promotes and values skill acquisition, learning, 
skill implementation and coping.   
 
We are unaware of studies which have compared individual and group approaches to peer 
support, and wonder whether patients vary in their responsiveness to such interventions.  
Groups could incorporate “social context”, particularly if wider commonalities were present 
beyond diabetes (eg community links).   We believe that comparing such approaches would 
assist in understanding the mechanisms behind any benefits or, alternatively, what the reasons 
are for any lack of benefit eg is it the patient mix, the intervention, the implementation of the 
intervention or even the conceptual framework.  A concept analysis by Dennis has contributed 
to our thinking about the role of peer supporters and the training that they will need (26).   
 
Heisler proposes that peer support can play an important role in identifying ways to overcome 
barriers to self care.  We would agree with this and have created a framework (Appendix 2) to 
achieve this that has been used in New Zealand, Australia and the US (5,6,27,28).   Also shown 
are examples of how the framework can be used to generate discussion between peer and 
person with diabetes in either a group or 1:1 situation.   
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We propose the following principles for the trial, beyond the pre-set requirements: 
 Discussing and addressing barriers to self care should provide a context for appraisal and 
informational and emotional support. 
 The trial should be able to combine evaluating the efficacy of the intervention with an 
evaluation of the mechanisms and issues behind the intervention. This would mean that 
even if the trial is negative, new knowledge would be gained for future trials. 
 The trial should allow a comparison of the efficacy of 1:1 peer support, a group approach, a 
combined approach and normal care without peer support.  We believe this question, of 
whether an individual or group approach is best is important and may remain unanswered 
unless a specific trial is undertaken  
 The trial should assess uptake of group peer support and any wider population impact. 
We have therefore devised a 2x2 factorial trial with an initial barriers survey and geographical 
clusters (defined by local government boundaries known as Parish Councils and including one 
or more villages or small towns) being allocated to neither intervention, a 1:1 peer support 
intervention, a community based peer support group intervention or both interventions.  
B. PERTINENT PREVIOUS AND ONGOING WORK OF THE APPLICANT GROUP 
David Simmons is the lead community diabetologist for Cambridgeshire, working between 
primary care and specialist services and therefore ideally placed for a community based trial of 
peer support.  He has been involved in a range of community based research and service 
activities designed to increase peer and lay support for those with diabetes.  This has included 
the establishment of the first South Asian diabetes support group in the United Kingdom in 
1986 in Coventry which continues to this day.  Attendance at the group was associated with 
improved knowledge and glycaemia (29).   In New Zealand he established a lay diabetes 
community health worker (CHW) programme for the unemployed (30), introduced CHW 
interventions for the prevention of diabetes in high risk communities (largely Maori and Pacific 
family members (31,32), established 10 diabetes support groups for Maori, Pacific and rural 
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communities and helped evaluate a rural “diabetes club” where clinical care and peer support 
occurred concurrently (33).  He has created a perceived “Barriers to Diabetes Care” evaluation 
framework used in New Zealand (5,6), rural Australia (27) and a deprived area of the US (28). 
Jonathan Graffy has considerable experience in primary care research, on diabetes and more 
widely. This includes conducting one of the largest randomised trials of volunteer peer support 
(for breastfeeding mothers) (34).  This has much in common with the planned diabetes trial and 
included a qualitative evaluation of participants’ perceived support needs (35).  He is Clinical 
Lead for the East of England Primary Care Research Network (PCRN-EoE) which will engage 
general practices to recruit and follow up participants in the planned trial (www.pcrn-eoe.org).  
He is currently conducting research on patients’ experiences of diabetes care in local practices. 
He led the literature review group for the Dept of Health care planning policy report (36).  
Sarah Donald and Mark Evans have expertise in group structured education programmes 
(DAFNE-Dose Adjustment For Normal Eating) with emphasis on self-management and support 
from group members.  A component of the course focuses on goal setting and action planning, 
which patients discuss in pairs/groups independent of the trainer/healthcare professional.   Our 
centre trains other healthcare professionals to deliver education programmes recognized by 
National Institute of Clinical Health and Excellence (NICE).  We develop curriculae, training 
programmes and presentations used by other centres throughout the UK.   
Simon Cohn, a medical anthropologist, has researched a wide range of topics relating to 
patients’ experience of living with chronic illness, their health behaviours, and their interactions 
with medical professionals.   Previous publications include his initial PhD thesis investigating 
Type 2 diabetes patients’ understanding of the idea of empowerment (37), and relating to 
dietary adherence (38),  risk perception(39); how patients with chronic illness understand 
medical knowledge, particularly issues of ambiguity and uncertainty (40, 41); how the 
diagnostic process can lead to a wide range of unintended individual and social consequences, 
for example in relation to psychiatric labels (42,43); how relationships between medics/ 
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scientists and patients are frequently complex and multidirectional, involving negotiation and 
exchange (44,45). He has recently been appointed as Senior Lecturer within the General 
Practice and Primary Care Research Unit, as the first social scientist within the Dept Public 
Health Cambridge University. 
Toby Prevost has been involved as a trial statistician in four complex intervention behavioural 
trials in Type 2 diabetes over the past eight years, and in cluster-randomised trials including the 
Cambridgeshire Addition trial (46). His statistical research has included investigating the 
suitability of methods for the design of cluster-randomised trials. 
Charlotte Paddison is a research psychologist and has studied diabetes patients’ experiences 
with health services and the psychological impact of the diagnosis of diabetes on patients. 
Peter Robins is a person with diabetes who has undertaken the DAFNE course.  He is the Chair 
of the local Diabetes Care–Patient Advisory Committee (DCPAC) working to improve 
communication between patients, carers and health professionals and recommend 
improvements in diabetes care.  He is a member of the Cambridgeshire Primary Care Trust 
Diabetes Education Working Group. 
Amanda Adler helped develop type 2 diabetes risk models for use by health economists from 
the UKPDS (47).  She is on the NICE Appraisals committee for new technologies and the 
chairperson of the NICE national committee to address effectiveness/cost-effectiveness of new 
type 2 diabetes agents.  She has been involved in eg ADDITION (46), 4T (48) trials. 
Cathy Walsh, Liaison Psychiatry consultant, is experienced in specific psychological interventions 
(eg motivational interviewing, CBT) and in assessing and treating people with diabetes who 
develop psychiatric problems (eg. anxiety, depression, adjustment disorders).  
C. METHODS  
Intended Audience and Setting 
Our trial will focus on people with Type 2 diabetes across Cambridgeshire (population 
587,573):  Type 2 diabetes because it is more prevalent and because the experiences and needs 
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of people with Type 1 and Type 2 diabetes differ.  Diabetes was recorded among 19,579 people 
aged 17+ years on local General Practice registers in March 2007 (49).  The prevalence of 
diagnosed diabetes is 3.33%. The county includes over 80 towns and villages with Cambridge 
as the major town (population 120,000).   The economic base comes from agricultural, science, 
educational and service industries with a large commuter population.    
General care for diabetes available to Intended Audience 
In the 2006 UK National Diabetes Survey, 89% of Cambridgeshire respondents reported that 
they received diabetes checkups at their general practice, 8% at hospital (50). The area includes 
two specialist diabetes services (one in Cambridge, one in Huntingdon), a community based 
diabetes support service including diabetes specialist nurses and dietitians and 76 general 
practices with primary care physicians and practice nurses providing structured diabetes care.  
All care is free at the point of care.  The community diabetes services provide structured 
education for those with type 2 diabetes and in the 2006 Diabetes Survey 18% of all patients 
said they “were offered or had participated in a course to help them manage their diabetes in 
the last 12 months”.  Insulin therapy is often commenced in primary care with or without the 
support of the community diabetes specialist nurses.  General practices are computerized with 
comprehensive registers of patients with diabetes registered under a capitation system.  All 
practices are funded to participate in the Quality Outcomes Framework (QOF) which includes 
reporting on a number of indicators relating to the quality of diabetes care across the practice 
(51).  The service in Cambridge has a Diabetes Care Patient Advisory Committee (DCPAC), a 
group of volunteers with diabetes who have contributed to this proposal.  
Recruitment or approaches to reaching intended audience 
Two major recruitment methods into the trial will be used: 
1  General practices possess lists of almost all local patients with diabetes and will be 
approached to send out an invitation to patients to participate in the trial.   Practice registers will 
be screened for diabetes, excluding people known to have Type 1 diabetes, dementia, psychotic 
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illness or if it might be unsafe for a peer supporter to visit them at home.   Invitation letters, and 
one reminder, will be sent to all residents with diabetes in smaller Parish Council areas, and a 
random sample of those with diabetes from larger areas anticipating that one third will join the 
trial, aiming for 20 people per cluster.   Invitation letters will include the patient information 
sheet, consent form and a baseline survey relating to barriers to care (6).   Participation rates 
will be maximized by using the Dillman method (52) in relation to format, inclusion of a 
stamped addressed envelope and follow up of the mail out.   PCRN-EoE and Diabetes Research 
Network staff will support practice staff with recruitment.    
2  All of the villages and towns have a means to contact local residents through notice boards, 
parish magazines, social clubs, Women’s Institutes and local Parish Councils.  These 
organizations will be approached to help invite people with diabetes into the trial.   Materials 
distributed will include the same pack as supplied to patients invited by general practitioners.  
Participants recruited by community advertisement will also be screened. 
 
Potential participants responding to the invitation will be contacted for an appointment for 
baseline assessment at a convenient venue (including the local general practice where 
appropriate).   Participants will provide written informed consent at this assessment.   The three 
towns with existing diabetes support groups will be excluded from the trial (approximately 25% 
of those with diabetes), but residents will be invited to contribute to training and back-up cover 
for the peer supporters recruited for the trial (Cambridge, Wisbech, Huntingdon). 
 
We believe that there are a number of reasons why general practice teams, potential peer 
supporters and participants will be keen to participate in this trial.   
 For general practices, this study has the potential to improve their patients’ health by 
overcoming some of the barriers which frustrate current care. Local practices have responded 
enthusiastically to other diabetes studies (46, 53). Practical, governance and financial aspects 
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of study participation will be aided by PCRN-EoE, which will also be able to take over 
research nurse work on the study if needed.  
 Potential peers will benefit from interesting and personally relevant training. Many people 
with diabetes are keen to share experiences and support others, but a particular advantage of 
doing so through this trial is that it will be provide a safe and supported framework for the 
peers.  Their expenses will be paid, but they will not be paid for their time.  Such a payment 
could undermine their role as “peers” who share common experiences with the other 
participants and could be viewed as against the “spirit of peer support” (22)). 
 Potential participants will be individually invited by their general practitioner as well as 
through community networks. Peer support will be established on a local community basis 
and endorsed by local health services.  Educational resources will be available to all 
participants and the trial will be run in a way to ensure that all participants know that their 
experiences and outcomes are important to the study team.   
In view of the behavioural nature of the trial, and the need for a control group, mass media will 
not be approached, although if recruitment is low, this decision may need to be reviewed.   In 
the trial documentation, participants will be advised that they will receive different forms of 
educational and/or personal support.   
Approaches to implementing peer support programs that address the 3 core components:   
We have devised a 2x2 factorial study design with geographical clusters allocated to neither 
intervention, a 1:1 peer support intervention, a community based peer support group 
intervention or both a 1:1 and group intervention. All three programmes would assist daily 
management and living with diabetes as well as social and emotional support by promoting self 
efficacy and providing buddying, mentoring and modeling.  The group approach would also be 
able to provide wider social support.  All participants will receive access to educational 
materials and normal care from their healthcare providers.   The three intervention groups will 
draw their discussion topics from the barriers to diabetes care identified in the mail survey 
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(filtered to protect privacy in the group sessions), and also from a list of core topics for the 
programme to cover.  Within the combined individual and group support arm of the trial, 
participants will be encouraged to agree which topics should be covered individually, and 
which should be discussed in the group sessions. The qualitative analysis will explore the 
impact of the different delivery modes on the content discussed and participants’ perspectives 
on its value to them.   We have summarised the way that the different intervention programmes 
will provide the three core components of peer support. 
Content: Educatn  
resource 
& normal 
care 
Assist in daily 
manage- 
ment and living 
with diabetes 
Social and  
emotional  
support 
Social  
Context
ual 
support 
Linkage to clinical  
Care 
Interventn:      
Individual 
1:1  
support 
Yes Sharing 
experiences  
& mentoring 
Individual 
discussion  
of social and 
emotional 
aspects of living 
with diabetes 
No Individual review of  
care plan, linkage 
via  
Diabetes Specialist  
Nurse (DSN) if 
needed 
Group 
support 
Yes Sharing 
experiences  
& co-mentoring in  
group 
Group discussion 
of  social and 
emotional aspects 
of living with 
diabetes 
Yes Group discussion of  
accessing services.  
Linkage via DSN  
if needed 
Combined  
support 
Yes Sharing 
experiences  
& mentoring 
(group 
and/or 
individually) 
Individual and/or 
group discussion 
of social and 
emotional aspects 
of living with 
diabetes 
Yes Both components  
As above. 
Normal care Yes - -  - 
Delivering the individual 1:1 approach: 
In the 1:1 peer approach, peers would be allocated a caseload of up to 10 individuals depending 
on their time.  The peer would be from any of the 1:1 clusters, but resident as near to the 
participant as possible.  Peers would follow their training in relation to the participant.  
Participants would be expected to have completed each aspect of the framework within 6 
months. 
Delivering the group approach:  
The groups would be geographically based and therefore held largely within walking distance 
of the participant residence.  Groups are expected to include 20 individuals on average, but this 
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will vary according to size of community.  The size and dynamics of such groups will be 
allowed to evolve naturalistically, but will be described.  Each group would have two leads, 
preferably from the cluster, although this may not be practicable for some of the smaller 
villages.  A further volunteer would also be appointed and trained.   The group would progress 
through the barriers framework as with the 1:1 approach, but as a group rather than as 
individuals.  Contact between meetings would generally be encouraged, to widen the peer 
support action.   The group would also be encouraged to develop wider social programmes 
within their village/town and to attract others with diabetes from the cluster who were not in the 
trial, providing it did not compromise the dynamics of the group.  Alternatively, new groups 
could arise should membership become too large.  Temporary group leaders and new leadership 
training may be needed in such instances. 
Delivering the combined group and 1:1 approach 
Peers would be trained to deliver both the 1:1 and group interventions.  Participants who drop 
out of the groups would be followed up 1:1 by the trained peers.  Individuals who require 
additional input beyond the groups would also be followed up in the 1:1 setting, comparable to 
the 1:1 approach.. 
The Peers 
Patients consulted through the Diabetes Care Patient Advisory Committee (DCPAC) have 
made a number of recommendations regarding the peers: 
 This is about patient support, not an educational intervention.  Peers would need careful 
training in the peer support package about strict limits in terms of clinical management and 
“education”  
 The peer would be somebody with diabetes, who is not a health professional, willing to help 
others understand their diabetes from the point of view of someone with diabetes.   The 
emphasis would be on how they have overcome their condition (i.e. they would need to be 
able to be a role model and have a pre-existing understanding of diabetes).  It was felt that 
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such information given by a person with diabetes would be taken “in a different way”, 
would help encourage people to overcome difficulties and would come from a different 
perception of management than a health professional.   
 The peer would need to be “like” the person being supported in relevant ways eg age, 
socioeconomic group.  Geographically based groups would have this as a commonality.   
Young people would be likely to want a young peer/peer group 
 Peers should be voluntary and could be expected to give 4-10 hours/week with no payment 
but costs covered.  Peers would require “basic people skills” and would need careful 
selection. 
 Support could be a few minutes on the telephone, face to face or any other way - this would 
be expected to evolve.  Frequency of contact would depend on time available, need (i.e. 
baseline status) and how far down the support programme the participant was.  Dependency 
would need to be avoided. 
Peers will be sought from the recruited cohort as well as local diabetes services and primary 
care by both recommendation and invitation.  Peers would need to come from intervention 
clusters (or outside the study area for 1:1 peers including Cambridge, Wisbech and 
Huntingdon).  Criteria for selection will be developed.  Participants who became peers would 
be excluded from the randomized trial (but part of a study of the impact on peers themselves).  
A succession strategy will ensure that if peer leaves there is more than one peer available. We 
will train reserve peers from outside the study area, or from areas with pre-existing support 
groups to provide back-up cover. 
Peer Training 
Training of peers would be undertaken separately for the 3 intervention programmes.  This will 
cover: A) the theoretical basis of peer support and behaviour change interventions, drawing on 
Bandura’s framework (Appendix 1) the barriers framework (Appendix 2), and Heisler’s causal 
model for peer support (above); B) basic knowledge about diabetes including food, physical 
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activity, self-monitoring; C) group and/or individual support skills, including motivational 
interviewing techniques; D)  approaches to ensure safety of the peer, (particularly for those in 
the 1:1 programmes), communication with health professionals, confidentiality and data 
protection and managing negative emotions and depression. The final curriculum would be 
developed in the first 8 months and include the core items agreed by the successful Peers for 
Progress applicants.  Best practice examples of the curriculum components would be included 
from the applicant discussions and literature/available training manuals such as used for the 
Expert Patient Programme, the Goal Setting/Action Planning from DAFNE and the Irish RCT 
of peer support (22 and Appendix 3).   We will use role play (e.g. “dealing with difficult 
customers”), video feedback and adult learning approaches as part of the training in group work 
and/or individual support skills.  The training is anticipated to take 3-4 days with formative and 
summative assessments leading to the provision of training certificates.   Monthly meetings 
with the Diabetes Specialist Nurse would take place for the first 6 months and every 2 months 
thereafter to provide further educational development and contribute to quality assurance.   
Linkage with local clinical services 
Peers will be linked with local services through: 
 The training team will include members of the local diabetes and primary care services 
 Supervision will be by a diabetes specialist nurse employed for this purpose and co-located 
with the local diabetes services.  Supervision would include regular written reports and peer 
meetings.   The DSN role may be shared to ensure their continuing local clinical practice, 
although this would need to be in a clinical role unlikely to contaminate those in the other 
limbs of the trial.   
 Development of a referral pathway for patients reporting clinical difficulties.  Generally, 
these would be discussed with the supervising DSN. 
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This linkage framework will be created in a way that should the trial show peer support to be 
successful and cost effective, the service that trains and supervises peers could be 
commissioned as part of the local diabetes and primary care services. 
Intervention Timeline 
The intervention will have 3 phases: 
 Pilot stage to include formative evaluation of a short pilot in a non-study area (Cambridge 
city). 
 First 6 months of the trial, implementing a structured programme on a monthly basis 
 Second 6 months of the trial as a maintenance phase, where contact is maintained, but with 
a structure and frequency as agreed by the participants and peers. 
The latter will link into a 6 month translation stage, to allow transition of the optimal trial 
approach to peer support to a wider community wide approach while some of the trial team 
remain.   This is not funded within the current application and we will seek funding for this 
purpose from local sources.  
Approaches to refining procedures and peer support intervention in months 1 – 8 
Appendix 4 outlines the key activities in Months 1-8 including trial administration, intervention 
and evaluation.  Of particular importance is the piloting of the peer intervention after the 
developmental work.  The pilot study will be undertaken in months 6-8 in Cambridge, as it is 
not included in the study itself.  Volunteers will be sought through local practices and the 
diabetes services to pilot the individual and group peer support interventions.  After the 3 
month trial period, participants may want the intervention to continue and this would provide 
an opportunity to develop strategies ahead of each stage of the trial. 
Approaches to evaluation 
Evaluation will include quantitative, qualitative and economic components collected through a 
range of methods to minimize measurement burden on participants and evaluation costs.    
Quantitative analysis of trial outcomes:   
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Initial barriers mail survey during invitation into trial:  This will be undertaken at the time of 
invitation into the trial and based upon prior studies (5,6).   We expect to get some data on 
those who subsequently are not part of the trial.  This will help us to assess the generalisability 
and reach of the intervention.    
Baseline data collection: This will be at a local venue (e.g. general practice, community venue) 
and include consent to access participant health data (including metabolic and health utilization 
data).  Key metabolic outcomes are HbA1c, lipids and blood pressure, weight and 
hypoglycaemia.   HbA1c and lipids will be largely available from general practice/diabetes 
services as this is comprehensively (approximately 98%) collected through the Quality and 
Outcomes Framework for Diabetes.  Where this is not collected, blood will be drawn.  Blood 
pressure and weight will be measured in a standardized manner in view of the potential 
variability in quality from clinically colleted data.  Information on hypoglycaemia will be 
collected by questionnaire.  Health service utilization will be assessed through clinical records 
including ambulance use.  Relevant demographic and health data will be collected.  Specific 
questionnaires relating to self management will include those agreed across the Peers for 
Progress groups and likely to include questions relating to self-efficacy (54), diabetes self-care 
activities (55), medication adherence (56), family and friends subscale of the Chronic Illness 
Resources Survey (57).  Quality of life will be assessed using the European Quality of Life-5 
Dimensions (EQ 5D) which is well validated in the UK (58) and does not overburden 
participants. 
6 months (mid point) data collection:  This will include questionnaires completed by telephone 
and collection of existing health data 
12 month (final) data collection: This will include comparable data to the baseline data 
collection. 
Data collection:  It is anticipated that some baseline and follow-up data will be collected by 
practice nurses at the participants’ practices (working in separate measurement sessions), or by 
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research assistants employed by the Primary Care Research Network (Clinical Lead is J Graffy) 
or Diabetes Research Network (Primary Care Lead is S Griffin), both of which are keen to 
collaborate on this trial.   
Qualitative analysis (Simon Cohn) 
A key dimension of this proposal is the suggestion that the value of peer support, both one-to-
one and in groups, is likely to be complex and multidimensional, and as a consequence difficult 
to assess solely using pre-determined and restrictive measures. Crucial to this study, therefore, 
will be the parallel collection of observation data from the peer training, debriefing and 
intervention sessions, the interview data from a sample of the participants, peers and project 
staff, in order to provide a more rich and nuanced record of both types of interventions. The 
aims of the qualitative analysis will be to explore the meaning of peer support as understood by 
peers and participants, their perspectives on the advantages and disadvantages of individual 
versus group support and ways that it might be improved. By analysing the data to establish 
common themes and concerns, we hope to be able to formulate a more sensitive understanding 
of the central mechanisms at play, and the significant differences when delivered to an 
individual compared with a group.   The qualitative component will primarily be managed by S. 
Cohn, who has had extensive experience in similar research using qualified assistants. The data 
will be collected throughout the intervention period, providing a unique longitudinal record of 
the project as the interventions are delivered, and patients increasingly participate. Transcripts 
and notes will all be entered on NVivo data software to provide a common dataset that can be 
integrated with the quantitative and descriptive variables. 
Economic analysis (Amanda Adler) 
We will perform an economic evaluation to answer the following questions from the 
perspective of the National Health Service:   Among individuals with diabetes in 
Cambridgeshire – (1) What are the costs associated with each method of peer support? (2) 
What is the change in effectiveness (HbA1c) and utility (quality of life) associated with each 
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method of peer support? (3) What are the costs associated with this change?   We will measure 
utility using the EQ5D.  We will model cost utility to estimate incremental cost effective ratios 
comparing 1:1 peer support to the absence of 1:1 peer support and group support to the absence 
of group support.  We will use the UKPDS Outcomes model to assess potential years-of-life 
gained given changes in HbA1c.  
Reach to and engagement of intended audience 
The GP registers and Quality and Outcomes Framework data provide a denominator for the 
prevalence of diabetes across the county (3.3%).  The local health board (the Primary Care 
Trust) has offered to assist with any data available.  From this and local GP data (anonymised to 
avoid any privacy issues), we hope to be able to get a denominator for each cluster.  This should 
allow an estimate of participation, both for the trial and uptake of peer support.   Characteristics 
of those participating will be known from the baseline data collection.  Some data will also be 
available on non-trial participants through the mail survey.   Further data on individuals initially 
not engaging may become available in clusters randomly allocated to groups or both peer 
interventions through the local networking and de novo attendance at the groups.  Such 
individuals will not be seen as part of the randomized controlled trial, but will be invited to be 
assessed through the trial and any changes assessed as a retrospective pre / post-intervention 
comparison.   Peers will undergo the same measurements as the participants to assess any 
changes in a pre- post manner. This will allow assessment of the impact of the programme on 
their health and self-management behaviour. 
With routinely collected clinical data (eg HbA1c, lipids, blood pressure) being so 
comprehensively collected under QoF, we would also hope to be able to assess any change in 
metabolic control for all of those with diabetes in the cluster.   Again, we would find a way by 
which this data could be provided in an anonymised way.  We would also be able to assess 
some changes in health service utilization within clusters (eg by assessing hospital admission 
rates by postcode). We will use the RE-AIM (reach, effectiveness, adoption, implementation, 
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and maintenance) framework which takes a broad perspective of issues that are important to 
policy makers to evaluate the public health benefits of the approaches tested (59).  
Intervention fidelity  
The extent, completeness and quality of the implementation of the intervention will be assessed 
during the above qualitative and quantitative evaluation, the peer-diabetes specialist nurse 
interactions, meeting records and activity logs prepared by the peer supporters. These will 
include attendance and the content of peer support discussions. We plan to develop this work in 
further discussions with Wendy Hardeman, a colleague in the Cambridge General Practice 
Research Unit (60). 
Special issues 
Reasons for drop out are particularly important and individuals will be carefully followed up 
and interviewed where possible.   Family members and carers would be invited to participate 
into both 1:1 and group approaches through the person with diabetes.  They would be asked to 
complete a questionnaire adapted from the patient questionnaire and would be included in the 
qualitative analyses.   
Data management and analysis (Toby Prevost-statistician) 
The trial design is randomised two-by-two factorial, testing main effects of Peer support versus 
no peer support (factor 1) and Group versus individual (factor 2).   Randomisation to the four 
arms will be at the level of the village/area (“cluster”), with patients in the same village/area 
cluster randomised to arm. The justification for cluster randomisation is (1) to enable feasible 
group sizes in villages/area (2) to minimise contamination arising from contact between 
participants in the same village/area (3) bearing in mind that, within the two group arms and to 
a lesser extent in the peer-individual arm, clustering of outcomes would already exist even with 
an individual randomised design, reducing the marginal effect of cluster randomisation on 
sample size inflation.   A restricted randomisation method that incorporates cluster-level 
stratifiers will be used, with randomisation performed centrally by a third party independent of 
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trial coordination, free from access to the study database, and with clusters identified by unique 
study numbers without access to village/area names.   The primary outcome will be HbA1c. A 
plausible and achieved effect size difference in mean HbA1c in another study (19) is 0.36. We 
propose a realistic effect size in the range 0.3 to 0.4 in difference in mean HbA1c for each 
factor as worth detecting. A recent trial in patients recruited from Cambridgeshire and 
Oxfordshire (53) has demonstrated a standard deviation of HbA1c between patients of 1.25. 
The Cambridgeshire ADDITION trial provides a recent and local estimate of the intracluster 
correlation coefficient for HbA1c of 0.037 (46).  
 
In the proposed study we anticipate being able to recruit a mean of 20 patients per randomised 
villages/area. Allowing for 10% dropout in access to records of HbA1c at study follow-up, we 
therefore anticipate a mean cluster size of 18 participants at the analysis stage.  With 1520 
participants recruited in 76 randomised village/area clusters (20 per cluster), and allowing for 
four clusters to withdraw from the study without allowing access to patient follow-up data, we 
anticipate that 1300 participants (90% of 1440) will be followed up with an HbA1c. There will 
be 90% power to detect a difference of 0.3 in mean HbA1c for each of the two factors at the 5% 
level of significance, allowing for a design effect due to clustering of 1.63, based on mean 
cluster size of 18 participants per cluster and ICC of 0.037. There will also be 90% power to 
detect a difference of 0.4 in mean HbA1c between any two of the four arms, and these 
comparisons offer protection against any unexpected interaction that might be observed 
between the two factors.   As a sensitivity analysis for this sample size calculation, in the event 
of a higher observed ICC, for example arising from the interaction between grouped 
participants, this coefficient would need to be approximately twice as large (0.07) to be able to 
effect a reduction in power from the desired 90% to a minimally acceptable 80%. For context, 
the ICC in a previous trial was 0.047 (61) 
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 1:1 Peer Support No 1:1 Peer support 
Group 380 recruited  
19 randomised areas 
325 HbA1c follow-up 
270 other outcomes follow-up 
18 followed-up areas 
380 recruited  
19 randomised areas 
325 HbA1c follow-up 
270 other outcomes follow-up 
18 followed-up areas 
Not 
group 
380 recruited  
19 randomised areas 
325 HbA1c follow-up 
270 other outcomes follow-up 
18 followed-up areas 
380 recruited  
19 randomised areas 
325 HbA1c follow-up 
270 other outcomes follow-up 
18 followed-up areas 
Other measures may not be able to be ascertained from medical records and a reduced follow-
up rate of 75% from questionnaires is assumed. With 1080 followed-up (15 participants per 
cluster), there will be 90% power to detect sufficiently small effect size differences in each 
factor of 0.25sd for factorial main effects, and 0.35sd for pairwise comparisons between arms. 
Statistical Analysis:  All analyses will account for the clustered design through the use of linear 
mixed effects for modelling continuous outcomes and simple comparisons of proportions, and 
Generalised Estimating Equations with exchangeable correlation matrix for modeling binary 
outcomes. Where a baseline of an outcome is available there will be an adjustment for this 
covariate in order to improve the precision of the estimated intervention effects. Participants 
with a missing value for baseline will be retained using the method of White et al. The analysis 
will follow guidelines for the approach for factorial trials (62,63). The methods will be adapted 
to allow for varying intracluster correlation by arm where this is identified. The influence of 
missing data for the primary outcomes will be investigated using the multiple imputation 
method of Rubin outlined in Shafer and the primary intention to treat analysis will be supported 
by per protocol analysis (64,65). Further before-after analyses will allow assessment of change 
in those clusters involved in the wait-list design. All analyses will be two-sided and assessed at 
the 5% level of significance. An interim estimation of variances, cluster sizes, cluster 
withdrawal, and participant follow-up and questionnaire return rates will be made to ensure 
adequate study power to detect effect sizes in the stated range. A trial analysis plan will be 
developed prior to the analysis. 
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The following Sections D, E, and F do not count toward the 20-page limit for the previous 
sections. 
 
D. READINESS TO PARTICIPATE IN COLLABORATIVE RESEARCH GROUP  Experience with 
collaborative research or evaluation projects and readiness to collaborate with other 
investigators in (a) exchanging curricula and approaches to peer support, (b) identifying and 
implementing key common evaluation indicators (metabolic control, self management 
behaviors, quality of life), (c) collaborative publications reporting cross cutting themes of the 
research. 
 
This is an experienced research group with wide experience in collaborative research and we 
are keen to collaborate with other groups. 
 
A The group has been involved in curricula development in DAFNE (a national 
educational/empowerment programme in the UK), lay health worker training in New 
Zealand and peer support in breastfeeding and diabetes in the UK and New Zealand. 
 
B The group has been involved in identifying key common evaluation indicators in 
metabolic control (eg in diabetes in pregnancy (66), in diabetes overall (67)), self 
management behaviours (eg readiness to change lifestyle (68), peer support for 
breastfeeding (35), Barriers to Diabetes Care tool in New Zealand, Australia and the United 
States (5,6,27,28), psychological factors (69)  
. 
 
C DS has worked with the University of Pittsburgh in an RCT based upon the Chronic 
Care Model using his barriers to care approach (70).  JG is a member of the UK 
National School for Primary Care Research (NSPCR) Recruitment and Retention 
working group.  We have recently submitted two papers on improving recruitment and 
retention to primary care studies (reviewing the literature and reporting a nominal group 
exercise with research staff). The Peers for Progress programme offers an ideal 
opportunity for a publication reviewing issues in recruitment to peer support studies. 
 
 
E.  IRB APPROVAL AND INFORMED CONSENT   Provide a brief discussion about the ethical 
implications of this study, how human subjects will be protected, and regulations for assuring 
such protection that govern the applicants and their institutions. 
 
1. The major ethical issue is around ensuring liaison with the usual health care providers and 
service purchasers with whom we already work.   
2. A further issue relates to the end of the trial and how peer support might be integrated into 
normal care at the end of the trial if successful.  (As peers are to remain unpaid, the only 
additional expenses would be operating costs, most of which would take place in the fist 6 
months of the trial.  The area has a Diabetes Care Patient Advisory Committee and 
discussions will be held depending on the outcome of the trial.)  
3. Confidentiality by peer supporters. (Selection of peers should include a general practitioner 
reference or review of application.  Peer training should cover confidentiality) 
4. Confidentiality in support groups (Cover in peer training. Include in group rules at start of 
group) 
5. Access to GP records.  (Patients will be identified from searches of GP registers, conducted 
by practice staff, or by PCRN staff with honorary contracts form the practices to cover this. 
Invitation letters will be sent directly from practices, so recruitment data need not be 
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transferred out of the practices.  Individual participants will then provide written consent for 
research staff to access their records for follow up). 
6. We will ensure ongoing support for the peers, which will enable the team to identify and 
address unexpected ethical issues if they arise.     
There is a fully functioning Ethics Committee in the area for protection of participants.  We will 
apply for approval before commencing the research and meet all NHS ethics and Research 
Governance requirements. 
 
F. REFERENCES Provide a bibliography of the references cited in the Background and Methods.  
The applicants may choose their preferred reference style but it should be clear and consistent 
in the application. 
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Appendix 1 Factors in Bandura’s social cognitive theory (24,25) 
Environment: Factors physically external to the person; provides opportunities and social support 
Situation: Perception of the environment; correct misperceptions and promote healthful forms 
Behavioral capability: Knowledge and skill to perform a given behavior; promote mastery 
learning through skills training 
Expectations: Anticipatory outcomes of a behavior; model positive outcomes of healthful 
behavior 
Expectancies: The values that the person places on a given outcome, incentives; present 
outcomes of change that have functional meaning 
Self-control: Personal regulation of goal-directed behavior or performance; provide 
opportunities for self-monitoring, goal setting, problem solving, and self-reward 
Observational learning: Behavioral acquisition that occurs by watching the actions and 
outcomes of others’ behavior; include credible role models of the targeted behavior 
Reinforcements: Responses to a person’s behavior that increase or decrease the likelihood of 
reoccurrence; promote self-initiated rewards and incentives 
Self-efficacy: The person’s confidence in performing a particular behavior; approach 
behavioral change in small steps to ensure success 
Emotional coping responses: Strategies or tactics that are used by a person to deal with 
emotional stimuli; provide training in problem solving and stress management 
Reciprocal determinism: The dynamic interaction of the person, the behavior, and the 
environment in which the behavior is performed; consider multiple avenues to behavioral 
change, including environmental, skill, and personal change. 
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 Appendix 2 Barriers framework (5,6) used in the initial patient survey and how it can be used 
to provide a framework to generate discussion between peer and person with 
diabetes in either a group or 1:1 situation. 
BARRIER TO CARE DESCRIPTION 
(EXAMPLES) 
Example of Strategy that peers could 
use 
PSYCHOLOGICAL   
Spiritual health belief Believe cause/cure should 
be sought spiritually/within 
Where possible gain support from  
relevant religious authority 
Alternative health belief Prefers uses alternative 
health models/treatments 
Emphasise importance of maintaining  
treatments advised by health care  
professionals 
Public health belief Believes the public should 
bear more financial 
responsibility for health care 
Emphasise importance of self care  
independent of who pays 
Self factors – motivation Psychological – motivation, 
attitudes, laziness, denial 
Motivational interviewing approaches  
to key issues 
Self factors – self efficacy No confidence, external 
locus of control, 
low self-efficacy 
Motivational interviewing approaches 
to  
key issues 
No symptom cue No physical symptoms Emphasise need to prevent future harm- 
Provide support in continuing self care 
Priority setting Others needs priority over 
own (e.g. children, elders) 
Provide strategies to help prioritise  
diabetes-reminder where appropriate 
Negative perceptions of 
time 
Not enough time (education 
provided too quickly) 
Provide strategies to help prioritise  
diabetes-reminder where appropriate 
Emotional Fear, shame emotion 
anxiety, worry – lack of 
hope 
Discuss and support-emphasise that this  
is normal and how to overcome 
Precontemplative Strictness of regime, giving 
up things I enjoy 
Working through strategies to achieve  
lifestyle and other goals 
EDUCATIONAL   
Low diabetes knowledge Lacks general/specific 
diabetes knowledge 
Where to obtain information and  
who to see 
Low knowledge of service Unaware of services 
available 
Explanation of how to navigate through  
health system and provision of support  
if need be 
INTERNAL PHYSICAL   
Self factors/other health  
conditions 
Diabetes (e.g. amputation) 
and non-diabetes related 
(e.g. arthritis) 
Support for discussing with health  
professionals 
Physical effects of 
treatment 
Pain of glucose monitoring,  
Drug side-effects 
Support for discussing with health  
professionals 
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EXTERNAL PHYSICAL   
Personal finance Income in relation to costs Advice in ways to obtain benefits,  
reduce costs 
Service/physical access Transportation, wheelchair 
entry 
Advice in ways to obtain transport 
Unhelpful health 
professional in past 
Past encounter with health 
professional leading to 
conflict or without expected 
communication or clinical 
expertise 
Emphasise importance of self care  
independent of past problems, support  
with problem solving re: overcoming 
any continuing problems 
PSYCHO-SOCIAL   
Unsatisfactory/ 
inappropriate  
diabetes care or education 
Wrong information 
provided or information 
provided in inappropriate 
way 
Emphasise importance of self care  
independent of past problems, support  
with problem solving re: overcoming 
any continuing problems 
Group pressure Pressure from others not to 
adhere to advice 
Support to “do the right thing” 
Prejudice  Impression of 
discriminatory practice  
due to diabetes or for other 
reasons 
Advice on ways to overcome any  
discrimination 
Lack of family support Family consumes diabetic 
food, resists 
change of lifestyle 
Advice on strategies to increase family  
support 
Family demands Pressure to spend 
time/money on the  
family rather than their 
diabetes 
Advice on how to reduce family 
demands 
Unsupportive macro-
environment 
Feeling of lack of support in 
the community, e.g. access 
to low fat foods 
Advice on how to obtain support 
Inappropriate cultural 
messages 
Attitude, ethnicity of 
workers, appropriateness of 
communication 
Emphasise importance of self care,  
support with problem solving re:  
overcoming any continuing problems- 
could accompany patient 
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Appendix 2 Programme from Dublin Trial (22) 
MEETING 1 
INTRODUCTION 
 Introduction to each other 
 What is peer support? 
 Ground rules 
 Discussion on course content (9 
sessions) 
 Video/DVD 15 mins 
 Entitlements in diabetes 
 Identifying a substitute peer 
supporter 
 Contact details for the group 
MEETING 2 
HEART AND VASCULAR 
DISEASE 
 Why is it so important? 
 How you can reduce your risk of 
heart disease and other vascular 
complication 
o Hypothetical individual and what 
they would advise them to do 
 Questions relating to heart disease 
including blood pressure and 
cholesterol medication and taking 
tablets 
MEETING 3 
BLOOD SUGAR LEVELS 
 Information on 
hypo/hyperglycaemia 
 Blood sugar testing 
Questions on blood sugar levels 
What to do when you are sick 
 
MEETING 4 
HEALTHY EATING 
Discussion of healthy ‘eating plate’ 
 Laminated picture of the ‘healthy 
plate’ 
Healthy eating quiz and discussion of 
answers 
Questions on healthy eating in diabetes 
MEETING 5 
MEDICATION 
 Control of type 2 diabetes 
o Diet 
o Tablets 
o Insulin 
Questions regarding medication 
including side effects 
MEETING 6 
EXERCISE 
 Importance of exercise 
 Use of pedometer 
o Each person will be given a 
pedometer 
Questions about exercise 
Maybe arrange a walk in locality 
MEETING 7 
FOOT CARE 
 Why foot care matters in diabetes 
 Discussion on how to check feet 
o Laminated sheet to cover all 
aspects of foot care 
Questions relating to the feet 
Information on local chiropody 
services 
MEETING 8 
EYE AND KIDNEY 
COMPLICATIONS 
 What happens to the eyes and 
kidneys in diabetes 
 Importance of good blood pressure 
and blood sugar control in order to 
prevent complications 
Questions relating to eye and kidney 
disease 
MEETING 9 
LIVING WITH DIABETES 
This is intended to be a relatively open session in which the group can discuss 
any remaining concerns and consider whether they would like to continue to 
meet 
Importance of follow up data collection! 
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Appendix 4 Timeline 
Months Trial Administration Intervention  Evaluation 
1-8  Prepare Participant  
information leaflets 
Develop educational  
materials including website 
Formative evaluation 
 Secure ethics approval Finalise criteria and 
process for selection of 
peers 
Select and customize  
measurement instruments 
 Recruit Project 
Manager  
and lead diabetes  
specialist nurse for 
pilot 
Finalise curriculum and 
peer support programme 
Develop qualitative 
evaluation, intervention 
fidelity evaluation  
and economic evaluation. 
 Recruit and train  
evaluation staff 
Identify areas in 
Cambridge  
for 3 month pilots 
Identify community 
networks  
for recruitment 
 Advertise for  
intervention team 
Pilot training one peer 
group and 1:1 peer support 
set up in Cambridge 
Finalise baseline barriers 
survey 
 Create database  Approach practices to  
participate in the study 
   Commence mail survey 
9-12  Liaison with GPs,  
Community 
 Complete mail survey 
 Recruit intervention  
team-start month 10 
Identify peers Recruit participants 
 Data entry and data  
checking 
Train peers Undertake baseline 
participant assessments inc 
HbA1c 
  Roll out educational tools 
(all groups)-month 11 
Obtain health utilization 
data 
  Roll out peer interventions 
-month 11-12 
 
13-16   Complete roll out of  
interventions months 13-14 
Collect observational/  
qualitative  data 
  Intervention underway- 
complete structured  
programme 
 
17-18 Data entry and  
data checking 
Intervention underway- 
complete structured  
programme 
Mid-point questionnaire 
(mail/telephone/web based) 
   HbA1c collection 
19-22  Ongoing Peer 
contact/support programme 
Collect observational/  
qualitative  data 
23-26  Complete trial Final data collection point 
   Obtain health utilization 
data 
   Collect qualitative data 
27-32 Data entry and  
data checking 
Support peers Analyse data, write reports 
  Translation/Handover  
 
